The New Drug Application for an additional rheumatoid arthritis (RA) indication of Methotrexate Injection has been accepted by NMPA, which is a new milestone following the China approval for psoriasis ...
SHENZHEN, CHINA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 30 July ...
Methotrexate is a primary disease-modifying anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA) by reducing inflammation and suppressing the immune system. The American College of ...
Please provide your email address to receive an email when new articles are posted on . The maximum methotrexate dose for inflammatory skin diseases is 1 mg/kg, not to exceed 25 mg per week. Onset of ...
A commonly prescribed cancer and arthritis drug that is sometimes used as an oral abortifacient is facing prescription roadblocks in the wake of the Supreme Court's overturning of Roe v Wade. "It's ...
Quantifying the risk of malignant melanoma from methotrexate use proved difficult in this new study, with the authors calling for larger studies with longer follow-up to guide future practice in the ...
China Medical System Holdings Limited (the“Company”, together with its subsidiaries, the“Group” or“CMS”) is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results